Literature DB >> 27028006

Comparison of anti-inflammatory mechanisms of mango (Mangifera Indica L.) and pomegranate (Punica Granatum L.) in a preclinical model of colitis.

Hyemee Kim1, Nivedita Banerjee2, Ivan Ivanov3, Catherine M Pfent4, Kalan R Prudhomme5, William H Bisson5, Roderick H Dashwood1,6, Stephen T Talcott1, Susanne U Mertens-Talcott7,8.   

Abstract

SCOPE: Tannin-rich fruits have been evaluated as alternative prevention strategies for n class="Disease">colorectal cancer based on their anti-inflammatory properties. This study compared tannin-rich preparations from mango (rich in gallotannins) and pomegranate (rich in ellagitannins) in the dextran sodium sulfate-induced colitis model. METHODS AND
RESULTS: In rats, mango and pomegranate beverages decreased intestinal inflammation and the levels of pro-inflammatory cytokines in mucosa and serum. The mango beverage suppressed the ratio of phosphorylated/total protein expression of the IGF-1R-AKT/mTOR axis and downregulated mRNA expression of Igf1, Insr, and pik3cv. Pomegranate decreased p70S6K and RPS6, as well as Rps6ka2, Map2k2, and Mapk1 mRNA. In silico modeling indicated a high binding of docked of gallic acid to the catalytic domain of IGF-1R, which may suppress the activity of the enzyme. Ellagic acid docked effectively into the catalytic domains of both IGF-1R and EGFR. In vitro assays with lipopolysaccharide-treated CCD-18Co cells using polyphenolic extracts from each beverage, as well as pure compounds, corroborated the predictions made in silico.
CONCLUSION: Mango polyphenols inhibited the IGF-1R- AKT/mTOR axis, and pomegranate polyphenols downregulate the mTOR downstream pathway through reductions in ERK1/2. These results suggest that extracts rich in gallo- and ellagitannins act on different molecular targets in the protection against ulcerative colitis.
© 2016 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  Colitis Mango mTOR pathway Pomegranate Rat

Mesh:

Substances:

Year:  2016        PMID: 27028006      PMCID: PMC5026564          DOI: 10.1002/mnfr.201501008

Source DB:  PubMed          Journal:  Mol Nutr Food Res        ISSN: 1613-4125            Impact factor:   5.914


  64 in total

1.  Proinflammatory cytokine synthesis by mucosal fibroblasts from mouse colitis is enhanced by interferon-gamma-mediated up-regulation of CD40 signalling.

Authors:  T De L Karlson; C V Whiting; P W Bland
Journal:  Clin Exp Immunol       Date:  2007-02       Impact factor: 4.330

Review 2.  The role of anti-inflammatory drugs in colorectal cancer.

Authors:  Dingzhi Wang; Raymond N DuBois
Journal:  Annu Rev Med       Date:  2012-09-27       Impact factor: 13.739

Review 3.  AKT/PKB and other D3 phosphoinositide-regulated kinases: kinase activation by phosphoinositide-dependent phosphorylation.

Authors:  T O Chan; S E Rittenhouse; P N Tsichlis
Journal:  Annu Rev Biochem       Date:  1999       Impact factor: 23.643

4.  Anticarcinogenic effects of polyphenolics from mango (Mangifera indica) varieties.

Authors:  Giuliana D Noratto; Michele C Bertoldi; Kimberley Krenek; Stephen T Talcott; Paulo C Stringheta; Susanne U Mertens-Talcott
Journal:  J Agric Food Chem       Date:  2010-04-14       Impact factor: 5.279

5.  Polyphenol-rich sorghum brans alter colon microbiota and impact species diversity and species richness after multiple bouts of dextran sodium sulfate-induced colitis.

Authors:  Lauren E Ritchie; Joseph M Sturino; Raymond J Carroll; Lloyd W Rooney; M Andrea Azcarate-Peril; Nancy D Turner
Journal:  FEMS Microbiol Ecol       Date:  2015-01-14       Impact factor: 4.194

6.  Small-molecule inhibition and activation-loop trans-phosphorylation of the IGF1 receptor.

Authors:  Jinhua Wu; Wanqing Li; Barbara P Craddock; Kenneth W Foreman; Mark J Mulvihill; Qun-sheng Ji; W Todd Miller; Stevan R Hubbard
Journal:  EMBO J       Date:  2008-06-19       Impact factor: 11.598

7.  The TSC-mTOR signaling pathway regulates the innate inflammatory response.

Authors:  Thomas Weichhart; Giuseppina Costantino; Marko Poglitsch; Margit Rosner; Maximilian Zeyda; Karl M Stuhlmeier; Thomas Kolbe; Thomas M Stulnig; Walter H Hörl; Markus Hengstschläger; Mathias Müller; Marcus D Säemann
Journal:  Immunity       Date:  2008-10-09       Impact factor: 31.745

8.  The ellagitannin colonic metabolite urolithin D selectively inhibits EphA2 phosphorylation in prostate cancer cells.

Authors:  Carmine Giorgio; Pedro Mena; Daniele Del Rio; Furio Brighenti; Elisabetta Barocelli; Iftiin Hassan-Mohamed; Donatella Callegari; Alessio Lodola; Massimiliano Tognolini
Journal:  Mol Nutr Food Res       Date:  2015-09-13       Impact factor: 5.914

9.  4-Amino-6-arylamino-pyrimidine-5-carbaldehyde hydrazones as potent ErbB-2/EGFR dual kinase inhibitors.

Authors:  Guozhang Xu; Marta C Abad; Peter J Connolly; Michael P Neeper; Geoffrey T Struble; Barry A Springer; Stuart L Emanuel; Niranjan Pandey; Robert H Gruninger; Mary Adams; Sandra Moreno-Mazza; Angel R Fuentes-Pesquera; Steven A Middleton
Journal:  Bioorg Med Chem Lett       Date:  2008-07-10       Impact factor: 2.823

10.  Temporal and spatial analysis of clinical and molecular parameters in dextran sodium sulfate induced colitis.

Authors:  Yutao Yan; Vasantha Kolachala; Guillaume Dalmasso; Hang Nguyen; Hamed Laroui; Shanthi V Sitaraman; Didier Merlin
Journal:  PLoS One       Date:  2009-06-29       Impact factor: 3.240

View more
  15 in total

Review 1.  Dietary plant miRNAs as an augmented therapy: cross-kingdom gene regulation.

Authors:  Ritu Trivedi; Mehar Hasan Asif; Prabodh Kumar Trivedi
Journal:  RNA Biol       Date:  2018-12-10       Impact factor: 4.652

2.  Immunomodulatory Properties of Pomegranate Peel Extract in a Model of Human Peripheral Blood Mononuclear Cell Culture.

Authors:  Miodrag Čolić; Marina Bekić; Sergej Tomić; Jelena Đokić; Dušan Radojević; Katarina Šavikin; Nataša Miljuš; Milan Marković; Ranko Škrbić
Journal:  Pharmaceutics       Date:  2022-05-27       Impact factor: 6.525

3.  Ellagic acid and human cancers: a systems pharmacology and docking study to identify principal hub genes and main mechanisms of action.

Authors:  Hamid Cheshomi; Ahmad Reza Bahrami; Maryam M Matin
Journal:  Mol Divers       Date:  2020-05-14       Impact factor: 2.943

4.  An increased autophagic flux contributes to the anti-inflammatory potential of urolithin A in macrophages.

Authors:  Yaw Duah Boakye; Laura Groyer; Elke H Heiss
Journal:  Biochim Biophys Acta Gen Subj       Date:  2017-10-12       Impact factor: 3.770

Review 5.  Multifaceted Health Benefits of Mangifera indica L. (Mango): The Inestimable Value of Orchards Recently Planted in Sicilian Rural Areas.

Authors:  Marianna Lauricella; Sonia Emanuele; Giuseppe Calvaruso; Michela Giuliano; Antonella D'Anneo
Journal:  Nutrients       Date:  2017-05-20       Impact factor: 5.717

6.  Pomegranate peel extract alters the microbiome in mice and dysbiosis caused by Citrobacter rodentium infection.

Authors:  Nadja S George; Lumei Cheung; Devanand L Luthria; Monica Santin; Harry D Dawson; Arvind A Bhagwat; Allen D Smith
Journal:  Food Sci Nutr       Date:  2019-07-07       Impact factor: 2.863

Review 7.  Intestinal Anti-Inflammatory Activity of Terpenes in Experimental Models (2010-2020): A Review.

Authors:  Maria Elaine Araruna; Catarina Serafim; Edvaldo Alves Júnior; Clelia Hiruma-Lima; Margareth Diniz; Leônia Batista
Journal:  Molecules       Date:  2020-11-20       Impact factor: 4.411

8.  Genistein improves inflammatory response and colonic function through NF-κB signal in DSS-induced colonic injury.

Authors:  Rui Zhang; Jian Xu; Jian Zhao; Yuzhe Chen
Journal:  Oncotarget       Date:  2017-05-26

Review 9.  Could Pomegranate Juice Help in the Control of Inflammatory Diseases?

Authors:  Francesca Danesi; Lynnette R Ferguson
Journal:  Nutrients       Date:  2017-08-30       Impact factor: 5.717

Review 10.  A Review on Ethnopharmacological Applications, Pharmacological Activities, and Bioactive Compounds of Mangifera indica (Mango).

Authors:  Meran Keshawa Ediriweera; Kamani Hemamala Tennekoon; Sameera Ranganath Samarakoon
Journal:  Evid Based Complement Alternat Med       Date:  2017-12-31       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.